Seeking Alpha

Enzon Pharmaceuticals (ENZN -11.5%) flips an early pre-market gain to trade lower after the...

Enzon Pharmaceuticals (ENZN -11.5%) flips an early pre-market gain to trade lower after the company unveiled a special dividend, a move that comes as the biopharmaceutical company concluded an earlier review of strategic alternatives and a workforce reduction. Late last year, Carl Icahn divulged a 13.3% stake in the company, and was taking an active interest in its operations and direction.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs